Inhibition of GC3/M TK- (human adenocarcinoma) cell growth in vitro.
C#CCN(CC1=CC2=C(C=C1)NC(=NC2=O)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,2130
CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(CC#C)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,48
CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(CC#C)C3=CC=CC=C3,10700
CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(CC#C)C3=CC(=C(C=C3)S(=O)(=O)C4=CC=CC=C4)C(F)(F)F,7500
CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(CC#C)C3=CC=C(C=C3)S(=O)(=O)C4=CC=CC=C4,1760
CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(CC#C)C3=CC=CC(=C3)C(F)(F)F,4300
CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(CC#C)C3=CC=C(C=C3)S(=O)C4=CC=CC=C4,3900
CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(CC#C)C3=CC=C(C=C3)C(=O)C4=CC=CC=C4,6200
CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(CC#C)C3=CC=CC(=C3)C(C)O,49000
CCN(CC1=CC2=C(C=C1)NC(=NC2=O)C)C3=CC=C(C=C3)S(=O)(=O)C4=CC=CC=C4,2600
CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(CC#C)C3=CC=CC(=C3)CO,54000
CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(CC#C)C3=CC(=CC=C3)I,5300
CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(CC#C)C3=CC(=C(C=C3)S(=O)(=O)NCC(=O)O)C(F)(F)F,77000
CC1=NC(=O)C2=C(N1)C=CC(=C2)CNC3=CC=C(C=C3)S(=O)(=O)C4=CC=CC=C4,14700
CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(CC#C)C3=CC=C(C=C3)S(=O)(=O)N4CCOCC4,5200
CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(CC#C)C3=CC=C(C=C3)S(=O)(=O)N4CCN(CC4)C,10000
CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(CC#C)C3=CC=C(C=C3)S(=O)(=O)N,26000
CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(CC#C)C3=CC=C(C=C3)[N+](=O)[O-],4800
CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(CC#C)C3=CC=C(C=C3)C#N,5000
CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(CC#C)C3=CC(=C(C=C3)C#N)Cl,6700
CCN(CC1=CC2=C(C=C1)NC(=NC2=O)C)C3=CC=C(C=C3)C(=O)C(F)(F)F,4000
CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(CC#C)C3=CC(=CC=C3)Br,5300
